Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
3(27%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
27%
Ph phase_1
3
27%
Ph phase_2
5
45%

Phase Distribution

3

Early Stage

5

Mid Stage

0

Late Stage

Phase Distribution11 total trials
Phase 1Safety & dosage
3(27.3%)
Phase 2Efficacy & side effects
5(45.5%)
N/ANon-phased studies
3(27.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

11

all time

Status Distribution
Active(3)
Completed(4)
Terminated(1)
Other(3)

Detailed Status

Completed4
Recruiting3
unknown3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
3
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 13 (27.3%)
Phase 25 (45.5%)
N/A3 (27.3%)

Trials by Status

completed436%
recruiting327%
withdrawn19%
unknown327%

Recent Activity

3 active trials
Showing 5 of 11
recruitingnot_applicable

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

NCT06945042
recruitingphase_2

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

NCT03786692
recruitingphase_2

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC

NCT06061146
completedphase_1

A HR20031 BE Study on Healthy Subjects

NCT05682495
completednot_applicable

Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.

NCT03435484
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06945042Not Applicable

ONC-LEUK-2406: The Impact of Systematic Financial Navigation in Acute Myeloid Leukemia

Recruiting
NCT03786692Phase 2

Phase II Randomized Trial of Carboplatin+Pemetrexed+Bevacizumab+/- Atezolizumab in Stage IV NSCLC

Recruiting
NCT06061146Phase 2

Tislelizumab Plus Concurrent Chemoradiation in Older With ESCC

Recruiting
NCT05682495Phase 1

A HR20031 BE Study on Healthy Subjects

Completed
NCT03435484Not Applicable

Using RCT to Increase Completion Rates of the Health Assessment Questionnaire.

Completed
NCT05240521Not Applicable

Efficacy and Safety, Tolerability of GA-AT0119 in IBS-C

Unknown
NCT02079220Phase 2

A Phase II Study of Ziv-aflibercept in Combination With Capecitabine/Oxaliplatin (XELOX) Chemotherapy in the Front-Line Treatment of Patients With Metastatic Colorectal Cancer

Withdrawn
NCT01176799Phase 2

Randomized Study of Doxorubicin and Cyclophosphamide With or Without Intermittent Sunitinib in the First-line Treatment of Locally Advanced or Metastatic Breast Cancer Patients With Measurable Primary Breast Tumor

Unknown
NCT01069081Phase 2

Docetaxel and Cisplatin Chemotherapy With or Without High Dose Proton Pump Inhibitor in Metastatic Breast Cancer

Completed
NCT02358720Phase 1

Single-fraction IMRT Versus External Beam Radiotherapy for Patients With Spine Bone Metastases

Unknown
NCT00756223Phase 1

Phase I Study of BI 831266 in Patients With Advanced Solid Tumours

Completed

All 11 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
11